GLP-1 and GIP therapies have been shown to: Clinical studies indicate that GLP-1 medications may help reduce liver fat and improve liver function in individuals with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)
That said, there is still a debate about whether these drugs protect the brain mainly by acting directly on the central nervous system or indirectly through improving metabolism throughout the body
Exenatide (Byetta ): risk of severe pancreatitis and renal failure
Pros Fully licensed and publicly traded, providing a layer of accountability Wide range of treatment categories beyond just weight loss Fast, convenient process for straightforward prescriptions Competitive pricing on many products, especially generics Discreet packaging and home delivery Available in all 50 states Cons Asynchronous consultations may feel impersonal, especially for complex treatments GLP-1 program relies on compounded medications, not brand-name drugs Limited provider continuity
Additionally, a Mounjaro production facility in Kobe, Japan, is expected to open in 2025
Delayed gastric emptying can be addressed with a low-fat diet, frequent small meals, blood glucose monitoring, and agents that increase gastric motility
/assets/images/provider/photos/2775905.jpeg)
